Skip to main content
. Author manuscript; available in PMC: 2019 Jan 1.
Published in final edited form as: J Urol. 2017 Jul 18;199(1):98–105. doi: 10.1016/j.juro.2017.07.038

Figure 1.

Figure 1

Flow diagram showing how patients were selected for study. Note that 28% of men with Gleason 6 and 14% of men with Gleason 7 were found at second biopsy to contain no cancer (GS 0), even with targeting; these men may represent an especially low-risk group (17).